Legacy Advisors, LLC Repligen Corp Transaction History
Legacy Advisors, LLC
- $821 Million
- Q2 2024
A detailed history of Legacy Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Legacy Advisors, LLC holds 5,732 shares of RGEN stock, worth $853,036. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,732
Previous 4,394
30.45%
Holding current value
$853,036
Previous $808,000
10.64%
% of portfolio
0.09%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$754 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$686 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$259 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$212 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.26B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....